Inventiva SA reports €4.5 million revenue for first nine months of 2025
I'm PortAI, I can summarize articles.
Inventiva SA reported €4.5 million in revenue for the first nine months of 2025, with cash and cash equivalents of €97.6 million and €24.7 million in short-term deposits as of September 30, 2025. The revenue included a $10 million milestone payment and $5 million in credit notes from Chia Tai Tianqing Pharmaceutical Group. The company expects its cash position to fund operations until early 2027, with potential extension if additional financing is secured.
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: Reuters The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments